SiriusHomeAbout usTeamContact


Dr. Khalid Islam, Partner

Khalid Islam is a co-Founder and Partner of Sirius Healthcare Partners and has over 22 years of experience in the pharmaceutical and biotechnology industry. He has been the Chairman and CEO of Gentium (a Nasdaq-listed company; 2009-2014) where he led the transition from a loss making to a cash flow positive and profitable company. Under his leadership the company value increased from US$25 mn leading to a successful all cash US$1 bn merger with Jazz Pharmaceuticals. From 1999-2008, he was President and CEO of Arpida where he transitioned the early-stage start-up to a SWX-listed company and raised US$300 mn in the IPO and follow-ons. From 1987-1999, he held various positions in HMR & MMD (now Sanofi-Aventis). From 1977-1987, he worked in academia at Imperial College (Univ. of London) and in Milan University, where he was a contract professor. He is a graduate of Chelsea College and received his Ph.D. from Imperial College, University of London. He holds several patents and has published over 80 articles in leading journals. He is an advisor to the venture group Kurma Biofund (Paris). He is a founder/co-founder of PrevAbr LLC (D.C.), BioAim LLC (LA) & Life Sciences Management GmbH (Zug). He is currently the Chairman of the Board of Directors of Pcovery (Copenhagen), Adenium (Copenhagen) and C10 Pharma (Oslo).

Email
Tel: +41 79 2794150